The Challenge:

In Non-Small Cell Lung Cancer (NSCLC), doctors are not familiar with, nor testing for, a critical prognostic Biomarker: c-Met protein overexpression. Yet, nearly 1 in 4 patients with NSCLC has c-Met protein overexpression, and with it, a worse overall prognosis.

How can we make doctors aware of the importance of c-met protein overexpression and the impact it has on their patients?

The Solution:

Spread awareness through a DSA campaign that highlights the overwhelming nature of c-met protein overexpression.

*All art assets were crated using AI engines, such as MidJourney.*